% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • rehdvm2004 rehdvm2004 Jul 23, 2013 10:06 AM Flag

    The extra money from the 6 million+ shares of stock is spoken for . . .

    to get Arikace into a world market. I still look for the breakthrough therapy as being efficacious NTM treatment. The CF/Pa will be competitive with the other inhalationals.

    But the next breakthrough is just sitting there screaming for a clinical trial. If you look at the ClinicalTrials website and search "inhalation AND antituberculosis drugs" . . . there is only one study of any significance. Thailand is performing a study on inhalational forms of the CDC recommended rotation of antituberculosis drugs. Those drugs should also be tried in INSM's IP liposome to see if the drugs "stick" in the fixed macrophages of the conducting airways and the alveolar macrophages. These are the sites where TB, not unlike NTM "set up housekeeping."


    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.20-0.02(-0.15%)Aug 29 4:00 PMEDT